Unilever PLC

Key Points
Dogecoin's price moves based on nothing more than short bursts of market excitement and pessimism.
It would take an almost impossible combination of factors for Dogecoin’s price to soar.
Instead of fixating on the next year, investors are better off thinking about the long term.
Dogecoin (CRYPTO: DOGE) might be one of the most volatile assets on planet Earth. It has periods where it skyrockets quickly, then comes crashing down. The highest price this meme coin ever reached was just under $0.74 in May 2021, during the cryptocurrency market boom in the spring of that year. It has generally been in a downward spiral since that record level. Dogecoin is now trading 82% below the peak.
But that doesn't prevent its biggest bulls from setting lofty targets for next year. Can Dogecoin reach the $1 mark in 2026? It's possible, but not probable.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
Hype is what influences Dogecoin's price
Markets these days are structured totally differently than in the past. Dogecoin is proof of this, as having a strong community of supporters might be the only thing keeping it relevant.
Dogecoin was created as a joke alternative to Bitcoin, with no true purpose other than that. But as an early entrant to the crypto world, it attracted fans that have carried the price. Nonetheless, Dogecoin's price moves based on short bursts of heightened interest. But what goes up has typically come down fast, which becomes clear when we look at Dogecoin's historical price chart.
Thinking through a best-case scenario makes things crystal clear
If Dogecoin's price does reach $1, it would imply a market cap of $152 billion. That is not insignificant. At that market cap, Dogecoin would rival the valuations of companies like Sony, Capital One, and Unilever.
But what would it take to get to this point? To put it simply, there would need to be an unprecedented surge in demand for Dogecoin tokens. This would introduce immense amounts of capital, which could rapidly drive up the price.
There are already Dogecoin spot exchange-traded funds (ETFs) on the market. These started launching more than a year ago. We're past the initial phase of excitement, so this catalyst has already played out and is now in the rearview mirror.
Perhaps Tesla Chief Executive Officer Elon Musk will post on social media site X (formerly Twitter) that he will deeply integrate Dogecoin into the operations of his various businesses. Or maybe he will announce a new venture whose primary goal is to boost adoption of Dogecoin. This could help jump-start the price.
Macro conditions might result in market exuberance. Additionally, Dogecoin's developer community might come up with some game-changing innovations that make the blockchain more compelling for a variety of use cases.
Even if all of these factors happened in the coming months, an outcome I view as having almost no chance of happening, Dogecoin still would probably fail to hit $1 next year.
Investors should avoid short-term price targets
While Dogecoin's bulls want the token's price to soar 673% during the next year to get to $1 before the end of 2026, this outcome just isn't in the cards without what amounts to a miracle. It's smart to temper expectations. Dogecoin's best days might be behind it.
And when it comes to having the right mindset, investors shouldn't look to buy stocks or cryptocurrencies with only a 12-month time horizon. The best strategy is to focus on the long term, paying attention to the quality of the assets in question instead of trying to predict price movements, a tempting activity that is largely a waste of time.
Dogecoin remains a dangerous gamble. If you're looking to take on more risk in your portfolio -- within reason -- there are lots of growth stocks to choose from. And in the world of crypto, Bitcoin is the best digital asset to own.
Should you buy stock in Dogecoin right now?
Before you buy stock in Dogecoin, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dogecoin wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $509,039!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,109,506!*
Now, it’s worth noting Stock Advisor’s total average return is 972% — a market-crushing outperformance compared to 193% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
*Stock Advisor returns as of December 22, 2025.
Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bitcoin and Tesla. The Motley Fool recommends Capital One Financial and Unilever. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Could Dogecoin Reach $1 in 2026?

Key Points
Dogecoin currently trades 82% below its record high, indicating declining market interest.
The meme coin needs a combination of unlikely factors to occur in a very short period of time.
True long-term investors will be skeptical of buying Dogecoin.
It seems like there are an unlimited number of cryptocurrencies on the market these days. Despite a crowded field, Dogecoin (CRYPTO: DOGE) was one of the early ones, and it's still around. The dog-themed blockchain network was launched in 2013. It's impressive that it's remained relevant for more than a decade.
Dogecoin currently trades 82% off its peak (as of Dec. 12), a high-water mark that was established in May 2021. But the meme coin has skyrocketed 110,000% in the past 10 years, generating phenomenal gains for its hodlers (crypto lingo for holders) in the process. The price right now is $0.1367 per coin. But can Dogecoin reach $1 by the end of 2025?
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Dogecoin is trying to make the improbable happen
Investors who are hoping that Dogecoin hits $1 before this year ends are asking for a monster gain in the digital asset's price in less than three weeks. This translates to a whopping 630% return. To be clear, this outcome isn't going to happen. It's not realistic to expect any asset's price to rise so much in such a short period of time.
Nvidia has been the hottest stock in recent years. Before reaching its record high in October, it took the leading artificial intelligence enterprise 30 months for the share price to soar roughly the same amount as Dogecoin would need to. If this return happened in a few short weeks, investors, analysts, and economists would all be convinced that there is something fundamentally broken with the market.
Dogecoin's historical gain has been spectacular. However, investors have had to deal with tremendous amounts of volatility. And the market appears to be losing its enthusiasm for the token. Dogecoin's price has tanked 57% in 2025 alone. The entire crypto market, which has also been under pressure, has shed about 6% of its value this year.
If Dogecoin's price did get to $1 by year-end, it would imply that the blockchain carries a market cap of $152 billion. This exceeds the valuations of companies like Pfizer, Unilever, and Lowe's, all of which sell in-demand products and services to their customers.
Let's assume that before 2026 starts, there is unprecedented quantitative easing that leads to burgeoning federal debt and monumental currency debasement, Dogecoin's developers also introduce game-changing innovations on the blockchain that result in a surge in usage, and capital allocators decide to buy the meme coin at historic rates. These are all extremely favorable factors, but they aren't happening in isolation or together.
Is Dogecoin still a smart buy today?
Dogecoin's price surely won't increase by 630% during the rest of this year. Those with more tempered expectations, though, might still be interested in speculating. Does this digital asset still present a smart buying opportunity? It depends on how you allocate your hard-earned savings.
The only people who will be even remotely interested are those looking to gamble on short-term price movements. A look at Dogecoin's historical price chart will reveal that it experiences very short-term bursts in positive sentiment, followed by crashes. The token is driven by unpredictable hype cycles that naturally draw momentum traders looking for a quick profit.
If you're a long-term investor, which I view as the best way to play the markets, then it won't be hard to convince you to avoid Dogecoin like the plague. As mentioned, the investment community might slowly be forgetting about this blockchain project, as the price has been in a downward spiral. Unless there are some incredible catalysts on the horizon, this should continue.
Dogecoin doesn't add any real-world value, and its supply is constantly increasing, an unfavorable comparison with a key competitor. The crypto it followed, Bitcoin, is completely decentralized, and it has a fixed supply of 21 million coins. Bitcoin is also being integrated into the traditional financial services industry in various ways. It's the much better choice for investors who have a five- or 10-year time horizon.
Should you invest $1,000 in Dogecoin right now?
Before you buy stock in Dogecoin, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Dogecoin wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $513,353!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,072,908!*
Now, it’s worth noting Stock Advisor’s total average return is 965% — a market-crushing outperformance compared to 193% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of December 8, 2025
Neil Patel has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Bitcoin, Nvidia, and Pfizer. The Motley Fool recommends Lowe's Companies and Unilever. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Will Dogecoin Reach $1 By the End of the Year?

The NASDAQ 100 Pre-Market Indicator is down -155.92 to 25,620.52. The total Pre-Market volume is currently 88,201,771 shares traded.
The following are the most active stocks for the pre-market session:
Nextdoor Holdings, Inc. (NXDR) is +0.59 at $3.12, with 6,172,356 shares traded. NXDR's current last sale is 141.82% of the target price of $2.2.
Oracle Corporation (ORCL) is -28.96 at $194.05, with 3,145,158 shares traded. As reported by Zacks, the current mean recommendation for ORCL is in the "buy range".
Novo Nordisk A/S (NVO) is +1.19 at $50.24, with 896,196 shares traded. NVO's current last sale is 94.17% of the target price of $53.35.
Planet Labs PBC (PL) is +2.55 at $15.49, with 894,925 shares traded. As reported by Zacks, the current mean recommendation for PL is in the "buy range".
Unilever PLC (UL) is +0.64 at $64.50, with 841,570 shares traded. As reported by Zacks, the current mean recommendation for UL is in the "buy range".
Nokia Corporation (NOK) is +0.11 at $6.33, with 810,196 shares traded. NOK's current last sale is 96.35% of the target price of $6.57.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Pre-Market Most Active for Dec 11, 2025 : NXDR, ORCL, NVO, PL, UL, NOK

The Procter & Gamble Company PG has delivered a dismal performance in recent months, weighed down by softer category demand, heightened promotional activity and a tough macro environment across several core markets. The company is contending with mounting pressures in North America and Europe, where increasingly value-conscious consumers and intensified competitive discounting are creating additional headwinds.
The slowdown in its performance has led the shares to decline 11.9% in the past three months, causing it to underperform the broader sector and the S&P 500 index, while it outpaced the Consumer Products - Staples industry. The Consumer Staples sector has declined 6.2% in the past three months, but the S&P 500 has rallied 5.1%. Meanwhile, the broader industry has fallen 13.9% in the same period.
PG's 3-Month Price Performance
Image Source: Zacks Investment Research
Amid these pressures, the Cincinnati-based consumer goods giant has slipped to fresh 52-week lows twice in the past two months. PG first touched a low of $144.09 on Nov. 10, 2025, and then fell further to a new 52-week low of $138.14 on Dec. 8, 2025, underscoring the market’s growing caution toward the stock.
PG’s performance is notably weaker than that of its competitors, Unilever Plc UL, BJ's Wholesale Club BJ and Albertsons Companies ACI, which declined 10.3%, 7.8% and 7.9%, respectively, in the past three months.
At the current share price of $139.63, PG trades 1.1% above its recent 52-week low mark of $138.14. Also, the PG stock trades 22.4% below its 52-week high of $179.99.
PG is trading below its 50 and 200-day moving averages, indicating a bearish sentiment at least for the near term. SMA is an essential tool in technical analysis that helps investors evaluate price trends by smoothing out short-term fluctuations. This approach provides a clearer perspective on a stock's long-term direction.
PG Stock Trades Below 50 & 200-Day Moving Averages
Image Source: Zacks Investment Research
What Is Behind PG Stock’s Recent Decline?
Procter & Gamble’s recent stock weakness reflects growing concern around its softening fundamentals and a tougher competitive landscape, as highlighted in its first-quarter fiscal 2026 earnings discussion. While the company posted its 40th consecutive quarter of organic sales growth, the underlying trends revealed pressure.
Category consumption decelerated through the quarter, with unit volumes essentially flat across key markets. In North America and Europe, two of PG’s most important regions, heightened competitive intensity has emerged as rivals lean aggressively into promotions, particularly in Fabric Care, Baby Care and Oral Care. This has weighed on market share, with global aggregate share down 30 basis points in the past three and six months.
PG also acknowledged slowing momentum in developed markets as value-conscious consumers become more selective and competitors push deeper discounting. Increased promotional spending in response is squeezing margins and raising investor concerns about near-term profitability. Meanwhile, the company’s ambitious restructuring, spanning supply-chain changes, portfolio streamlining and reductions of up to 7,000 non-manufacturing roles, signals that structural adjustments are needed to restore competitiveness.
Although innovation pipelines in categories like Tide, Pampers and SK-II remain strong, the near-term environment is challenging. The combination of softer category growth, intensifying price competition and ongoing restructuring has contributed meaningfully to PG’s recent stock decline.
PG’s Estimate Revision Trend
The Zacks Consensus Estimate for PG’s fiscal 2026 and 2027 EPS was unchanged in the last 30 days. For fiscal 2026, the Zacks Consensus Estimate for PG’s sales and EPS implies 3.2% and 2.6% year-over-year growth, respectively. The consensus mark for fiscal 2027 sales and earnings indicates growth of 2.9% and 5.7% year-over-year, respectively.
Image Source: Zacks Investment Research
Despite recent market pressures, analyst expectations for Procter & Gamble remain steady, reflecting confidence in the company’s long-term strategy and execution. The Zacks Consensus Estimates for fiscal 2026 and 2027 EPS have held firm in the past month, suggesting that analysts view current headwinds as manageable rather than structural.
For fiscal 2026, the company projected organic sales growth of up to 4% and modest EPS expansion, supported by innovation-led pricing, stronger productivity benefits and early contributions from restructuring initiatives. Additionally, there is optimism surrounding PG’s significant investments, ranging from its robust innovation pipeline to Supply Chain 3.0 and organizational streamlining, which is expected to drive enhanced margin leverage.
With management reaffirming its full-year guidance and highlighting improving momentum in China and Latin America, the stable estimates reinforce confidence that PG is positioned for gradual but profitable growth despite near-term volatility.
PG’s Premium Valuation
Procter & Gamble undoubtedly commands a high valuation, reflecting its strong market positioning, brand power and long-term growth potential compared with its peers. However, we believe that its valuation is too stretched at this time.
Despite the considerable decline in its share price, PG still trades at a significant premium to industry peers with a forward 12-month price-to-earnings (P/E) multiple of 19.42X. The current valuation is below its five-year high of 26.67X and ahead of the broader industry’s multiple of 17.34X.
At 19.42X P/E, Procter & Gamble is trading at a valuation higher than its competitors, like Unilever and Albertsons Companies. Unilever and Albertsons Companies have forward 12-month P/E ratios of 18.14X and 8.34X — lower than Procter & Gamble. Meanwhile, its competitor BJ's Wholesale Club has a forward 12-month P/E ratio of 19.54X, slightly higher than PG.
Image Source: Zacks Investment Research
Should You Still Buy PG?
Procter & Gamble’s recent share price decrease and its premium valuation create a paradox for investors. The stock’s drop to fresh 52-week lows reflects concerns around slowing category demand, intensified promotional activity and competitive pressure in key markets. Despite this weakness, PG continues to trade at a valuation premium, suggesting that investors still recognize its strong brand equity, category leadership and long-term earnings durability.
Analyst expectations reinforce this view, pointing to steady sales and EPS growth even amid short-term volatility. Management’s reaffirmed guidance, improving productivity and early benefits from restructuring, indicates confidence in the company’s ability to navigate current challenges.
For investors, PG’s setup offers a balanced perspective: while the recent decline may warrant caution for value-focused buyers, the Zacks Rank #3 (Hold) company’s premium valuation and stable outlook reflect ongoing confidence in its long-term growth potential. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Zacks Naming Top 10 Stocks for 2026
Want to be tipped off early to our 10 top picks for the entirety of 2026? History suggests their performance could be sensational.
From 2012 (when our Director of Research Sheraz Mian assumed responsibility for the portfolio) through November, 2025, the Zacks Top 10 Stocks gained +2,530.8%, more than QUADRUPLING the S&P 500’s +570.3%.
Now Sheraz is combing through 4,400 companies to handpick the best 10 tickers to buy and hold in 2026. Don’t miss your chance to get in on these stocks when they’re released on January 5.
Be First to New Top 10 Stocks >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Procter & Gamble Drops 11.9% in 3 Months: Buy the Dip or Stay Wary?

The GMO International Quality ETF is seeing unusually high volume in afternoon trading Tuesday, with over 2.4 million shares traded versus three month average volume of about 51,000. Shares of QLTI were off about 0.6% on the day.
Components of that ETF with the highest volume on Tuesday were Haleon, trading off about 0.6% with over 7.5 million shares changing hands so far this session, and Novo Nordisk, down about 0.7% on volume of over 6.8 million shares. Unilever is the component faring the best Tuesday, higher by about 3.3% on the day, while Diageo is lagging other components of the GMO International Quality ETF, trading lower by about 2.6%.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Tuesday's ETF with Unusual Volume: QLTI

NVIDIA Corporation’s NVDA shares jumped 1.7% on chipmakers and tech infrastructure having a good session.
Marvell Technology, Inc. MRVL slid roughly 7% after Carvana Co. (CVNA) claimed the S&P 500 spot many had anticipated would go to the chipmaker. CVNA soared 12.1%.
Shares of Confluent, Inc. CFLT skyrocketed 29.1% after International Business Machines Corporation IBM announced plans to acquire the data-infrastructure firm in a $11 billion deal.
Unilever PLC’s UL shares plunged 7% on consumer stocks losing out in the session.
Radical New Technology Could Hand Investors Huge Gains
Quantum Computing is the next technological revolution, and it could be even more advanced than AI.
While some believed the technology was years away, it is already present and moving fast. Large hyperscalers, such as Microsoft, Google, Amazon, Oracle, and even Meta and Tesla, are scrambling to integrate quantum computing into their infrastructure.
Senior Stock Strategist Kevin Cook reveals 7 carefully selected stocks poised to dominate the quantum computing landscape in his report, Beyond AI: The Quantum Leap in Computing Power.
Kevin was among the early experts who recognized NVIDIA's enormous potential back in 2016. Now, he has keyed in on what could be "the next big thing" in quantum computing supremacy. Today, you have a rare chance to position your portfolio at the forefront of this opportunity.
See Top Quantum Stocks Now >>
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
Unilever PLC (UL) : Free Stock Analysis Report
NVIDIA Corporation (NVDA) : Free Stock Analysis Report
Marvell Technology, Inc. (MRVL) : Free Stock Analysis Report
Carvana Co. (CVNA) : Free Stock Analysis Report
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Company News for Dec 9, 2025

Key Points
Major stock market indexes were mixed on Thursday.
Some AI stocks rose while others fell as earnings results kept coming out.
Investors came into the new week on Monday largely in wait-and-see mode, as the Federal Reserve will begin its two-day December meeting on Tuesday. The central bank's latest pronouncement on interest rates, which it will make on Wednesday afternoon, will play a huge role in investor sentiment heading into the remainder of the holiday season and into 2026. For now, though, investors didn't see anything that warranted large moves in the primary market benchmarks. The Nasdaq Composite (NASDAQINDEX: ^IXIC), S&P 500 (SNPINDEX: ^GSPC) , and Dow Jones Industrial Average (DJINDICES: ^DJI) all saw relatively modest declines on the day.
Index
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue »
Daily Percentage Change
Daily Point Change
Dow
-0.45%
-216
S&P 500
-0.35%
-24
Nasdaq
-0.14%
-32
Despite the relatively calm trading session, several individual stocks saw much larger moves on Monday. Read on to learn more about some high-flying companies as well as a couple of large businesses that have suffered some recent setbacks.
Top Stock Gainers Today
CFLT: +29%
Confluent (NASDAQ: CFLT) jumped on news that tech behemoth IBM (NYSE: IBM) had entered into an agreement to acquire the open-source data streaming company. Under the terms of the deal, Confluent shareholders will receive $31 per share in cash for their stock, valuing the company at $11 billion. As IBM sees it, integrating Confluent into its own technology platforms will allow the two companies' joint enterprise customer bases to deploy new generative and agentic AI solutions more effectively than they could separately. Meanwhile, Confluent co-founder/CEO Jay Kreps was excited by what joining Big Blue could mean for his company. Given the pace at which AI service providers are scrambling to scale up their businesses to meet unprecedented demand, it wasn't surprising to see that IBM shares also managed to gain a bit of ground Monday -- something that's relatively unusual for an acquirer making a major purchase of an AI stock.
WVE: +147%
A lesser-known company led the list of top stock market gainers on Monday. Wave Life Sciences (NASDAQ: WVE) soared nearly 150% during the regular session after the clinical-stage biopharmaceutical company announced positive results from a trial of its investigational obesity treatment. Wave's WVE-007 produced improvements in body composition, including reductions in fat mass and increases in lean mass after three months. Wave also demonstrated a favorable safety profile for the candidate treatment.CEO Paul Bolno said that the results exceeded Wave's expectations and put WVE-007 on a similar level as GLP-1 weight-loss drugs. In addition, with the potential to let patients take WVE-007 just once or twice per year, Wave hopes that patients could eventually be able to enjoy favorable health benefits without the need for more frequent injections.
Top Stock Losers Today
UL: -7%
Shares of global consumer products giant Unilever (NYSE: UL) were down on Monday, but don't let the decline trick you. The move follows the company's spinoff of its Magnum Ice Cream (NYSE: MICC) unit, which started trading as an independent company on Monday. Unilever shareholders who held shares last Friday were entitled to receive one share of Magnum stock for every five Unilever shares they held, but Monday's buyers of Unilever stock were no longer eligible. Magnum, which also owns the popular Ben & Jerry's ice cream brand, didn't get a huge bump out of the gate, but many investors believe that the ice cream unit could fare better on its own than it has under the thumb of the massive consumer stock's global empire.
APD: -9%
Finally, Air Products and Chemicals (NYSE: APD) dropped over 9% on the day. The maker of industrial gases and chemicals said that it is in advanced negotiations with Norway's Yara International to create a new partnership. Air Products would contribute its industrial gas capabilities as well as its exposure to low-emission hydrogen, while Yara would bring its ammonia production and distribution network to the table. Despite the potential benefits of the deal, investors seem to believe that the amount of capital required for the investment could put pressure on Air Products' balance sheet. More broadly, hydrogen projects haven't seen as much success as some investors had hoped, but a deal would mean Air Products would have more at risk if the two parties reach a final agreement.
Should you invest $1,000 in Confluent right now?
Before you buy stock in Confluent, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Confluent wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $540,587!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,118,210!*
Now, it’s worth noting Stock Advisor’s total average return is 991% — a market-crushing outperformance compared to 195% for the S&P 500. Don’t miss out on the latest top 10 list, available when you join Stock Advisor.
*Stock Advisor returns as of December 8, 2025
Dan Caplinger has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends International Business Machines. The Motley Fool recommends Confluent and Unilever. The Motley Fool has a disclosure policy.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Biggest Stock Movers Today, Dec. 8: CFLT, UL, & More

The DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive. Unilever plc (Symbol: UL) presently has an above average rank, in the top 50% of the coverage universe, which suggests it is among the top most "interesting" ideas that merit further research by investors.
But making Unilever plc an even more interesting and timely stock to look at, is the fact that in trading on Monday, shares of UL entered into oversold territory, changing hands as low as $55.05 per share. We define oversold territory using the Relative Strength Index, or RSI, which is a technical analysis indicator used to measure momentum on a scale of zero to 100. A stock is considered to be oversold if the RSI reading falls below 30. In the case of Unilever plc, the RSI reading has hit 25.5 — by comparison, the universe of dividend stocks covered by Dividend Channel currently has an average RSI of 53.7. A falling stock price — all else being equal — creates a better opportunity for dividend investors to capture a higher yield. Indeed, UL's recent annualized dividend of 2.1032/share (currently paid in quarterly installments) works out to an annual yield of 3.54% based upon the recent $59.48 share price.
A bullish investor could look at UL's 25.5 RSI reading today as a sign that the recent heavy selling is in the process of exhausting itself, and begin to look for entry point opportunities on the buy side. Among the fundamental datapoints dividend investors should investigate to decide if they are bullish on UL is its dividend history. In general, dividends are not always predictable; but, looking at the history chart below can help in judging whether the most recent dividend is likely to continue.
Click here to find out what 9 other oversold dividend stocks you need to know about »
Also see:
Air Services Other Dividend Stocks
CT Split History
Top Ten Hedge Funds Holding BRLS
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Unilever is Oversold

(RTTNews) - The Magnum Ice Cream Company N.V. announced that, on 8 December 2025, its ordinary shares will be admitted to: listing and trading on Euronext Amsterdam; listing on the Equity Shares category of the Official List of the UK Financial Conduct Authority and to trading on the London Stock Exchange's main market for listed securities; and listing and trading on the NYSE.
On admission, the company's issued and outstanding ordinary share capital will be 612,259,739 ordinary shares. The ordinary shares have a nominal value of 3.50 euros each and carry voting rights of one vote per share. As at 8 December 2025, there were 612,259,739 ordinary shares with voting rights.
Unilever PLC announced, on 6 December 2025, that it completed the demerger of its ice cream business, now known as The Magnum Ice Cream Company N.V.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

Magnum Ice Cream Announces Admission To Trading On Amsterdam, London And New York

The NASDAQ 100 Pre-Market Indicator is up 95.78 to 25,332.72. The total Pre-Market volume is currently 76,591,430 shares traded.
The following are the most active stocks for the pre-market session:
Direxion Daily TSLA Bull 2X Shares (TSLL) is +0.16 at $18.39, with 2,908,512 shares traded. This represents a 192.37% increase from its 52 Week Low.
Leverage Shares 2X Long CRCL Daily ETF (CRCG) is +0.15 at $2.50, with 2,142,014 shares traded. This represents a 32.87% increase from its 52 Week Low.
iShares Bitcoin Trust ETF (IBIT) is +0.97 at $52.00, with 1,799,990 shares traded. This represents a 20.99% increase from its 52 Week Low.
NVIDIA Corporation (NVDA) is +0.37 at $180.63, with 1,722,164 shares traded. Over the last four weeks they have had 9 up revisions for the earnings forecast, for the fiscal quarter ending Jan 2026. The consensus EPS forecast is $1.42. As reported by Zacks, the current mean recommendation for NVDA is in the "buy range".
Bitfarms Ltd. (BITF) is +0.1325 at $3.23, with 1,616,108 shares traded. As reported by Zacks, the current mean recommendation for BITF is in the "buy range".
iShares Ethereum Trust ETF (ETHA) is +0.0897 at $22.99, with 1,515,375 shares traded. This represents a 109.19% increase from its 52 Week Low.
Enterprise Products Partners L.P. (EPD) is +0.1726 at $32.70, with 1,303,559 shares traded. As reported by Zacks, the current mean recommendation for EPD is in the "buy range".
NIO Inc. (NIO) is +0.06 at $5.52, with 963,570 shares traded. NIO's current last sale is 81.18% of the target price of $6.8.
Novartis AG (NVS) is -0.45 at $129.99, with 810,863 shares traded. NVS's current last sale is 99.23% of the target price of $131.
Unilever PLC (UL) is +0.08 at $60.28, with 711,514 shares traded. As reported by Zacks, the current mean recommendation for UL is in the "buy range".
Circle Internet Group, Inc. (CRCL) is +2.36 at $75.00, with 614,480 shares traded. CRCL's current last sale is 56.82% of the target price of $132.
Oracle Corporation (ORCL) is -5.16 at $199.80, with 506,844 shares traded. As reported by Zacks, the current mean recommendation for ORCL is in the "buy range".
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.